Vol 3, No 2 (April 2014): Translational Lung Cancer Research (the 10th Congress of Spanish Lung Cancer Group I)


Rafael Rosell, Bartomeu Massuti, Niki Karachaliou

Review Article

10th Congress on Lung Cancer—updates on clinical trials: goal
Rosario García Campelo, Bartomeu Massuti, Joaquín Mosquera, Rafael Rosell
Concordance of IHC, FISH and RT-PCR for EML4-ALK rearrangements
Cristina Teixidó, Niki Karachaliou, Vicente Peg, Ana Gimenez-Capitan, Rafael Rosell
Hippo/YAP pathway for targeted therapy
Emanuela Felley-Bosco, Rolf Stahel
Targeted therapy in NSCLC driven by HER2 insertions
Solange Peters, Stefan Zimmermann

Review Article

State of the art in surgery for early stage NSCLC—does the number of resected lymph nodes matter?
Laura Romero Vielva, Manuel Wong Jaen, José A. Maestre Alcácer, Mecedes Canela Cardona

Review Article

Predicting resistance by selection of signaling pathways
Niki Karachaliou, Rafael Rosell, Miguel Angel Molina, Santiago Viteri
How old is “too old” for translational research?
Alain Vergnenegre, Romain Corre, Hervé Lena, Hervé Le Caer


The focused issue “the 10th Congress of Spanish Lung Cancer Group I” was commissioned by the editorial office, Translational Lung Cancer Research without any sponsorship or funding. Rafael Rosell, Bartomeu Massuti and Niki Karachaliou served as the unpaid Guest Editors for the focused issue.